Home/Prenostics/Lyndal Hesterberg

LH

Lyndal Hesterberg

Technology Lead

Therapeutic Areas

Prenostics Pipeline

Drug	Indication	Phase
Prenostics Test	Early Detection (Stage 0-2) - Ovarian Cancer in high-risk women	Pre-clinical

Leadership Team at Prenostics

Co-Founder & Chief Scientific Officer

Chief Executive Officer

View full Prenostics profile